Automated laboratory extractor GenoCTC

for the isolation of CTCs

Metastasis is the most catastrophic manifestation of cancer and the major cause of mortality. Circulating Tumor Cells (CTCs) are cancer cells found in the blood during metastasis. Being very rare, with one CTC per one billion hematopoietic cells, highly specific and sensitive technologies are imperative for their isolation. GenoCTC allows high throughput and more accurate separation of CTCs from whole blood. Effective isolation of CTCs can be extensively used for personalized care through non-invasive liquid biopsy. Early detection of cancer Development of acquired drug resistance Biology of metastatic development Relapse or prognostic information Real-time monitoring of therapeutic efficacy Identification of therapeutic target Separation performance Despite using whole blood (without pre-processing), GenoCTC provides high-purity CTCs and facilitates subsequent experiments and analysis with increased reliability Workflow Sample Preparation Use of 1 to 7.5mL of whole blood CTC-specific biomarkers Use of cancer cell-specific biomarkers User-friendly cartrîdge mounting Disposable cartridges to prevent cross-contamination between samples Sample loading and CTC separation Separation based on microfluidic and magnetophoresis High purity CTCs ready for downstream analysis Fully automated one-touch separation Analysis ICC (Immunocytochemistry) PCR,ddPCR-based Diagnosis NGS Single-cell genomics